Alessia Ciancio
Turin, 10126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Direct-Acting Antivirals in Patients with Comorbidities for the Simplified Management of HCV Infection: An Expert Review with a Focus on Sofosbuvir-Velpatasvir.
Journal: Viruses
Published: July 07, 2026
Baseline HDV-RNA Levels Could Stratify Clinical Risk Before, But Not After, Cirrhosis in Chronic Hepatitis D: A Multicentre European Study.
Journal: Alimentary pharmacology & therapeutics
Published: January 15, 2026
Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment.
Journal: Journal of gastrointestinal cancer
Published: December 07, 2025
The challenges of caring for HDV-positive patients: a narrative medicine perspective.
Journal: Panminerva medica
Published: September 03, 2025
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort.
Journal: World journal of gastroenterology
Published: July 07, 2025
Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study.
Journal: Journal of viral hepatitis
Published: May 28, 2025
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 14, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 06, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.
Journal: Viruses
Published: December 19, 2024
Editorial: PIVKA-II Facilitates Risk Stratification for HCC Following HCV Cure-Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: December 18, 2024
Last Updated: 09/26/2026